Inventor · disambiguated record
Andre Marozsan
Also filed as: MAROZSAN ANDRE · MAROZSAN ANDRE J
9 granted patents·3 pending applications·48 citations·filing 2011–2024
83Inventor score
Files withALEXION PHARMA INC4INOZYME PHARMA INC4INT AIDS VACCINE INITIATIVE1MA DANGSHE1PROGENICS PHARM INC1
Top patents by PatentIndex Score
12 records- 0189US8986697B2Antibodies for the treatment of Clostridium difficile-associated infection and diseaseMA DANGSHE·Filed 2011·Granted Mar 24, 2015·23 cites·24 claims
- 0287US10449236B2Treating seizure with recombinant alkaline phosphataseALEXION PHARMA INC·Filed 2015·Granted Oct 22, 2019·17 cites·20 claims
- 0384US9738688B2HIV-1 envelope glycoproteinINT AIDS VACCINE INITIATIVE·Filed 2013·Granted Aug 22, 2017·6 cites·19 claims
- 0474US11364284B2Methods of treating myointimal proliferationINOZYME PHARMA INC·Filed 2017·Granted Jun 21, 2022·2 cites·18 claims
- 0574US2025019677A1Methods of improving cardiovascular function and treating cardiovascular disease using a recombinant ectonucleotide pyrophosphatase phosphodiesterase (npp1)INOZYME PHARMA INC·Filed 2024·Application pending·0 cites
- 0665US11224638B2Treating seizure with recombinant alkaline phosphataseALEXION PHARMA INC·Filed 2019·Granted Jan 18, 2022·0 cites·16 claims
- 0760US12134790B2Methods of improving cardiovascular function and treating cardiovascular disease using a recombinant ectonucleotide pyrophosphatase phosphodiesterase (NPP1)INOZYME PHARMA INC·Filed 2018·Granted Nov 5, 2024·0 cites·25 claims
- 0857US2022354933A1Methods of treating myointimal proliferationINOZYME PHARMA INC·Filed 2022·Application pending·0 cites
- 0951US12428484B2Anti-ALK2 antibodies and uses thereofALEXION PHARMA INC·Filed 2019·Granted Sep 30, 2025·0 cites·18 claims
- 1045US11186832B2Treating muscle weakness with alkaline phosphatasesALEXION PHARMA INC·Filed 2017·Granted Nov 30, 2021·0 cites·23 claims
- 1142US10106583B2Materials and methods for producing cleaved, HIV-1 envelope glycoprotein trimersUNIV CORNELL·Filed 2015·Granted Oct 23, 2018·0 cites·16 claims
- 1239US2015175681A1Antibodies for the treatment of clostridium difficile-associated infection and diseasePROGENICS PHARM INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andre Marozsan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →